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STATE-OF-THE-ARTCLINICALARTICLE

Application of Polymerase Chain Reaction to the Diagnosis of Infectious Diseases
David N. Fredricks and David A. Relman

PCRandothersequence-basedmicrobialdetectionmethods,
once consideredto be only research tools, are being used
increasinglyin the clinical microbiologylaboratory.As this
technologyexpandsinto the clinicalarena,clinicianswill need
to learnits advantagesand limitationsso thatsoundjudgments
can be made. Astute clinicians know that results of blood
culturereports,whetherpositive or negative, must be interpreted using an understandingof the test employed and an
assessmentof the clinical scenario.Similarly,infectious diseases practitionerswill need to expandtheirunderstandingof
PCR-baseddiagnosticsso that these powerful tests are used
appropriately.
It is ourgoal to makePCR-baseddiagnosticsunderstandable
to clinicians.We will point out the limitationsof conventional
diagnosticmethodsfor infectiousdiseases, discuss the advantages and limitations of PCR-basedmethods, and mention
some currentand futureapplicationsof this technology.We
will not discussevery currentor pendingapplicationof PCRto
diagnosticmicrobiology;the readeris referredto otherpublications for additionaldetails [1-3]. We emphasizethe principles behindPCR-baseddiagnosis,andacknowledgea researchorientedbias in our viewpoint.
Thelimitationsof existingdiagnosticmethodsandthepotential
of PCR-baseddetectionand identificationmethodsare demonstratedby a case fromStanfordUniversityMedicalCenter.
A Case of Meningitis
A 53-year-oldwoman was seen in the emergencydepartment with a 5-hourhistoryof severe headacheand depressed
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mentalstatus.On physicalexamination,she had a fever (temperatureto 38.6?C),nuchalrigidity,andno evidenceof a rash.
Multiplegeneralizedseizureswere noted.Therapywith ceftriaxoneandvancomycinwas institutedin the emergencydepartment for empirictreatmentof meningitis,anda CT scan of the
brainwas obtainedpriorto a lumbarpuncture.Blood cultures
were obtainedafter antibioticshad been started,because of
difficultywith phlebotomy.The lumbarpuncturedemonstrated
cloudyCSF with an elevatedpressure,a WBC countof 17,500
cells/mm3(93%neutrophils),a proteinlevel of 756 mg/dL,and
a glucose level of 41 mg/dL(serumglucose level, 209 mg/dL).
Examinationof a gram-stainedsmear of the CSF was reportedto show many WBCs and many gram-negativediplococci, suggestingthe diagnosisof meningococcalmeningitis.
The patient ran a day care center, and the county health
departmentwas notifiedso thatantibioticprophylaxiscouldbe
startedfor case contacts.The patient'svancomycinwas discontinued,and penicillinwas addedto the ceftriaxonetherapy
for optimal coverage of Neisseria meningitidis.

On the second hospitalday, the gramstain of the CSF was
reviewed. The laboratoryconcluded that the gram-negative
organismsseen on the smearhad a coccobacillarymorphology
more consistent with Haemophilus influenzae than with

N. meningitidis.The penicillinwas discontinuedand ceftriaxone was continued.The patient'sconditionimprovedand she
was dischargedon the fifth day to completea course of outpatient intravenousceftriaxone.All blood and CSF cultures
were negative.Latexagglutinationtests performedon the CSF
were negative for Haemophilus group b, Streptococcus pneumoniae, group B Streptococcus, and N. meningitidis antigens.

The etiology of this patient'smeningitiswas not confirmed
using conventionalmethodsof cultivationand antigendetection. To identify the bacteriumresponsiblefor this patient's
illness, we used a sequence-basedapproachin our laboratory.
A sampleof the patient'sCSF was centrifugedto concentrate
bacteria,andthe pellet was digestedto liberatebacterialDNA.
This DNA was used as templatein a broad-rangePCR assay
designed to copy enzymatically(amplify) a portion of the
bacterial16S rRNA gene in vitro using a thermostableDNA
polymerase. Oligonucleotide primers complementary to
broadlyconservedregionsof the 16S rRNAgene were used to
amplify segments of the gene that also containedvariable,
phylogeneticallyinformativeDNA sequence(s)(figure1). The

This article is a U.S. government work, and is not subject to copyright in the United States.
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Why did the conventionalmicrobiologicaldiagnosticmethods fail in this case?Althoughmicroscopy(e.g., gramstaining)
may suggest an etiologic agent, it rarely provides definitive
evidence of infectiondue to a particularspecies. In this case,
microscopyinitially misidentifiedthe organismas consistent
with N. meningitidis.Fortunately,the clinicians continued
broadspectrumantibioticswhile awaitingcultureconfirmation
of the organism,andthereforecontinuedto treatfor the H. influenzae responsiblefor this patient'smeningitis.Had ceftriaxonebeen stoppedandpenicillinused alone,the outcomemay
have been distinctly less favorable.Clearly the microscopic
morphologyof organismsmaybe misleading,with conclusions
influencedby the trainingand subjectiveinterpretation
of the
microscopist.In othercases, the numberof organismsmay be
too low for visual detectionby microscopy.The failureof CSF
and blood culturesto providea diagnosisin this case can be
ascribedto the use of antibioticsbefore obtainingthe culture
samples.In the settingof meningitis,wherethe rapidinitiation
of antibioticsis paramount,this scenariois not unusual,especially when a lumbarpunctureis delayedbecausea headCT is
ordered.However, there are cases of bacterialmeningitisin
which culturesfail to yield the organism,even without the
institutionof antibiotics,furtherdemonstratingthe limitations
of culture-basedtechnology.The CSF latex agglutinationtest
for H. influenzaegroup b antigenwas negative in this case,
probablybecausethe responsibleHaemophilusspecies did not
possess groupb antigen,as has been notedfor otherbiotypeIII
isolates.
Limitations of Conventional Diagnostic Methods
Cultivation

strands,includingthe variableregionthatmay containa phylogeneti16S rRNA
informative
gene sequence.
sequences from bacteria present in the Gencally
sequence of the amplified product was then determined using
an automated DNA sequencer, and aligned with other known

fingerprint, and can be used to identify an unknown agent or
infer its evolutionary relationships with other previously characterized organisms. In our assay, samples of CSF and water
used as negative controls did not produce a PCR product,
indicating lack of bacterial DNA template. On the other hand,
CSF from the patient with meningitis produced a PCR product.

Sequencingand phylogeneticanalysisshowedthatthe organism presentin the patient'sCSF matchedthatof H. influenzae
biotype III [4].

For more than a century, the standarddiagnostic test in
infectiousdiseaseshas been in vitro cultivationusing artificial
media.Even today,clinicalmicrobiologylaboratoriesdevote a
majorityof theirefforttowardscultivationof clinical samples,
which is a testamentto the continuedutility of cultivation
technology.Formicrobesthatareeasily tamedin the petridish,
the sensitivity,specificity,ability to determineantibioticsusceptibilityand otherclinicallyrelevantbehavioralcharacteristics, and intrinsicamplificationof cultivationmake this approachattractive.Certainmicrobesmay requirespecialculture
media and conditions,so failure to consider these microbes
may yield negativecultureresults.Cultivatablemicrobesmay
also fail to grow after exposure to antibioticsor after poor
sample handling, renderinga culture-independent
approach
valuablein some circumstances.Similarly,cell culturecan be
used to detectsome virusesand intracellularmicrobes,but the
cost, labor,and time requiredfor this approachbeg for better
diagnosticmethods.
In contrast,other microbesare not so easily tamed in the
laboratory.Certainpathogenssuch as Bartonellahenselae are
fastidious,andotherhumanpathogenssuch as Mycobacterium
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otic selectionpressuresand the emergenceof antibioticresistance. Second, with more specifically directedantimicrobial
therapy,it is likely thatantibioticcosts woulddropandclinical
outcomeswould improve.These issues need to be addressed
with carefulstudies.
Anotherproblemwith cultivationin the laboratoryis that
certainorganismsconstitutea healththreatto laboratoryworkers who attemptto propagatethem. Organismssuch as Fran-
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Figure 2. Percentageof cultivatedand uncultivatedbacteriafrom
several selected bacterial divisions present in the ARB sequence
database.From [5] (used with permission).

leprae and Treponemapallidum continue to defy our attempts
at cultivation on artificial media. Efforts to grow viruses such
as human papillomavirus and hepatitis C virus in cell culture
have been equally frustrating.Why do these microbes resist our
cultivation attempts? Answers to this question remain obscure.
However, a more appropriate question may be "why are we
successful in getting so many human pathogens to grow in the
laboratory?"
It seems less surprising that there are culture-resistanthuman
pathogens when one considers the situation in environmental
microbiology. It is estimated that <1% of the bacteria present
on earth have been described to date using cultivation technology. When environmental niches are sampled to determine the
bacterial census, sequence-based techniques usually reveal
large numbers of microbes that fail to grow using standard
cultivation techniques; these organisms tend to be previously
uncharacterized. Figure 2 illustrates the relatively high percentage of uncultivated bacteria present in several selected cosmopolitan bacterial divisions, even in those divisions such as the
proteobacteria, actinobacteria, and low G+C gram positives
that contain known human pathogens. Of 36 bacterial divisions
noted by Hugenholtz, Goebel, and Pace in their review, 13
divisions are composed entirely of uncultivated organisms [5].
Therefore, we should be mindful of the limitations of cultivation technology, and should not be surprised when sequencebased methods reveal novel microbes associated with human
disease.
Other pathogens, such as mycobacteria and fungi, will grow
in the laboratory but may require prolonged periods of cultivation. In many cases, the delay between obtaining a culture
and the generation of a result necessitates empiric antibiotic
therapy, sometimes lasting for months. For these slow-growing
microbes, a cultivation-independent method would offer the
potential for rapid diagnosis. There are several potential advantages to a speedy diagnosis. First, one might reduce the use
of empiric antibiotics, which in turn could help reduce antibi-

causes of outbreaksamongworkersin the clinical microbiology laboratory.Thesehighly infectiousmicrobesmustbe handled in biological safety hoods or sent out to referencelaboratories where such facilities exist. Unfortunately,these
microbes are sometimes isolated from patientswho are not
suspectedof harboringsuch highly infectiouspathogens,and,
therefore,appropriateprecautionsare not used. A sequencebased diagnosticmethod could identify these hazardousmicrobes withoutrisk, since samples can be treatedto kill microbeswhile preservingnucleic acid for analysis.
Finally,successfulcultivationof a microbedoes not necessarily imply successful identificationof the microbe.Organisms isolatedon artificialmediamust still be identified,traditionally by using phenotypic tests such as the ability to
metabolizesugarsor growthin the presenceof certainchemicals or antibiotics.Althoughusually successful,these phenotypic tests have limited discriminatorypower in identifying
microbes,the resultsfor a given microbemay vary depending
on the state of the organism,and they are not always reproFor instance,the
ducibleandthey areusuallynonquantitative.
cell wall compositionof an organismmay vary dependingon
the selectionof growthmedia.
Serology
Serologic assays based on the detection of host-derived
antibodiesor microbe-derivedantigens have several limitations. Serologicdetectionof antibodiesmay not be helpfulin
the very acutestage of illness, becausethe host may not have
time to mount an antibodyresponse. For rapidly evolving
diseases,the host may succumbto infectionbeforeantibodies
can be produced.The immunocompromised
host may never
mount an appropriateantibodyresponse to infection, again
limitingthe utility of serologicassays. Detectionof microbial
antigensrequiresa relativelylarge microbialburden,which
limitsassaysensitivity.Unlikecultivation,whichdetectsbroad
groupsof microbes,serologicassaysmustbe orderedindividually and target narrow groups of organisms.In addition,
serologic assays requirespecific and reliableantiseraor antigens,whichmaynotbe available.If the cliniciandoes notthink
of the correctserologictest to order,the diagnosisis not made.
Microscopy/Histology
The direct detection of microbes in tissues or fluids by
microscopyhas limitedsensitivityand specificity.A relatively
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largenumberof microbesmust be presentbeforethey will be
visible by microscopy(e.g., 10,000 bacteriaper milliliter of
fluid). Even if the organismsare presentin sufficientlyhigh
concentrations,one mustuse the appropriatestainsand conditions (e.g., darkfieldfor treponemes)to makethemvisible. As
with serology,if one fails to considera particularmicrobe,then
one may miss that organismwhen using standardtechniques.
For instance,one will have difficultyvisualizingB. henselae
with a tissue gram stain, but may see the organismwith a
Warthin-Starrysilver stain or with immunohistochemical
methods. The limited specificity of microscopy reflects our
meagerabilityto speciateorganismsbasedon morphology.To
identifymicrobesby directexamination,one is dependenton
the trainingand experience of the microscopist,the correct
choice of stain and illumination,and the presence of large
numbersof organisms.These multiple variablesconspire to
make directexaminationa poor diagnostictest in many situations.
In our case of meningitis,all threeconventionaldiagnostic
methodsfailedto identifythe responsibleorganism.Is thisjust
an isolated case, or is there a problem with our diagnostic
Pneumoniais the most common infectious
armamentarium?
cause of death in the United States,with 4 million cases per
year [6, 7]. No etiologic agent can be identifiedin >35% of
cases of community-acquired
pneumoniawhen using conventional diagnostic methods such as cultivationand serology.
Betterdiagnosticmethodsare needed.

PCR

PCR is an enzyme-drivenprocess for replicatingDNA in
vitro. Using this technology,one is capableof turninga few
molecules of DNA into large quantities.Why is it useful to
have largeamountsof microbialDNA availablefor study?The
levels of microbialDNA presentin clinical samples are frequently too low for meaningfulmanipulationand measurement. PCR can producesufficientamountsof DNA so that
microbescan be detectedand identified.Because each unique
microbehas a unique complementof DNA (or RNA), DNA
can function as a molecularfingerprintto help identify microbes.CertainDNA sequences(e.g., bacterial16S rDNA) are
particularlyinformative,allowing one to distinguishmost microbes from one another.
In the PCR, a segment of DNA is copied in vitro by a
thermostableDNA polymerase enzyme in the presence of
buffer, magnesium, deoxyribonucleosidetriphosphates,and
to regionson
primers.Oligonucleotideprimerscomplementary
the coding and the noncodingstrandof the DNA templateare
responsiblefor specificityin the reaction,determiningwhich
region of DNA becomes amplified.As the primersannealto
their complementaryregions of DNA, DNA polymerasesattach to the primer-templatecomplexes and extend the DNA
strands,producinga copy of the DNA. Eachcopy of DNA may
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then serve as anothertemplatefor furtheramplification.Multiple roundsof heatingandcooling of the reactionmixturein a
thermalcycler produceroundsof melting of double-stranded
DNA, annealingof primerto single-strandedtemplates,and
extensionof DNA strands,to producea logarithmicincreasein
DNA. In the ideal scenario,the primerschosenin the PCRare
specific for a particularmicrobial gene, and hence do not
amplify nonspecifictargets such as human genes. Theoretically, one could startwith a single copy of the targetmicrobial
gene presentin the reaction,and generatebillions of copies of
DNA from that gene.
Although PCR is the best known and most widely used
nucleic acid amplificationtechnology,thereare otheramplification technologies in use. These technologies include the
transcription-based
amplificationsystem, stranddisplacement
amplification,ligase chain reaction,and Qf3replicasesystem.
In addition,therearemethodssuch as branchedDNA technology thatdo not amplifythe DNA, yet can detectlow levels of
DNA via signal amplificationfrom a probe. We will not
discussthese othertechniquesfurther;the readeris referredto
othersourcesfor more in-depthinformation[3].
There are several approachesfor using PCR to detect microbialDNA. The simplestapproachis specificPCR.Here,one
to a DNA targetthatis
designsprimersthatarecomplementary
specificfor the microbebeing assayed.Forinstance,by selecting uniqueregions of the Whipplebacillus' 16S rRNA gene,
one can createprimersthat will amplify only the 16S rRNA
gene fromthe Whipplebacillus, Tropherymawhippelii.
In contrast,with broad-rangePCR one attemptsto detect a
broadergroup of organismsby designing primers that are
complementaryto conservedregions of a particulargene that
aresharedby a given taxonomicgroup.Forinstance,one could
design primersthat are complementaryto regions of the 16S
rRNA gene that are sharedby most membersof the bacterial
domain,with the intentionof using the more variableregions
of the amplifiedsequence for identificationor phylogenetic
assessment[8]. In this situation,one would expect to amplify
any bacterial16S rDNA presentin the reaction.Between the
extremesof specific and domain-widePCR is a large middle
PCR.Here,one designsprimersthat
groundof taxon-restricted
are complementaryto conserved regions of a gene from a
particulargroupof organisms;eitherthe primersare not complementaryto the samegene segmentin othermicrobesoutside
the groupor the distributionof the gene itself is limitedto that
group. For instance, primers have been designed that will
amplify a segment of the DNA polymerasegene from all
membersof the herpesvirusfamily,but will not amplifyDNA
polymerasegenes from otherviral families.
Anothervariationof PCRis multiplexing,in whichmultiple
specific PCR assays are run simultaneouslyin the same reaction tube to test for multiple different DNA templates. In
multiplexPCR,severalsets of primersareaddedto the reaction
in orderto generateseveral differentPCR products.For in-
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stance,one couldhavea PCRassaydesignedto detectbacterial
DNA in CSF thatuses five differentspecificPCR reactionsin
one tube, with primerpairs directedtowardS. pneumoniae,
N. meningitidis, H. influenzae, Listeria monocytogenes, and the

group B Streptococcus.In such an assay, some method of
postamplification
analysisis neededto determinewhich organism is representedin a positive reaction.If the amplification
productsdifferin size, then gel electrophoresiswill providean
initialidea of which PCRreaction(s)took place. This approach
is sometimeshamperedby interferencebetweenprimerswithin
the same reaction.
Nesting of PCR increasesassay sensitivityand can increase
specificityas well. In nested PCR, one uses the productof a
primaryPCR reactionas templatein a second PCR reaction.
The firstPCRreactionamplifiesa microbialDNA targetusing
primerscomplementaryto the organismor groupof organisms
being assayed.In the second round,a sampleof the firstPCR
is addedto freshreactionmixturefor a secondPCRusing a set
of primersthatannealto regionsof the same gene, but at sites
internalto the previouspriming sites. For instance,the first
roundreactionmay producea 400-bp product,and the second
roundmay producea 200-bp productthat is a subset of the
400-bpproduct.(Inhemi-nestedPCR,one primerfromthe first
roundis used in the second roundreactionas well.) Increased
sensitivityis obtainedbecausethe targetis enrichedin the first
round of PCR, with subsequentdilution of other DNA and
inhibitors.Additionalspecificityresultsfromthe set of specific
primers employed in the second round. Even if nonspecific
amplificationoccurs in roundone, the nonspecificamplification productwill probablynot participateas templatein the
second roundbecause it is unlikely to have regions of DNA
complementaryto the second set of specific primers. The
problemwith nested PCR is thatit is highly proneto contamination with amplificationproducts,and thus must be performed with extreme care and interpretedwith even greater
caution.The usual efforts to inactivateamplificationproducts
in orderto preventcontaminationdo not workwithnestedPCR
because one needs to use amplifiabletemplatefrom the first
roundin roundtwo. OpeningPCR reactiontubes afterround
one and transferringamplificationproductsto new tubes are
conduciveto contamination.
How does one detect an RNA target, such as rRNA or a
segmentfromthe genomeof an RNA virus?A modificationof
PCR called reversetranscriptasePCR (RT-PCR)can be used.
In RT-PCR,an RNA templateis the initialtarget,and reverse
transcriptasecreatesa complementaryDNA copy of the RNA.
Oligonucleotideprimerscatalyzeconversionof a specific segment of RNA into DNA. Oncethe DNA templateforms,it can
be amplifiedas in standardPCR.
Confirmationand Identificationof PCR Products
Aftercompletinga PCR,one mustdetermineif the intended
PCRamplificationproductwas generated.Themost commonly
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usedmethodfor detectingPCRproductsin the researchlab has
been gel electrophoresis.The contentsof the PCR are loaded
into an agarose or acrylamidegel, an electrical gradientis
applied througha buffer solution, and the productsmigrate
throughthe gel matrix. The amplificationproductsmigrate
thoughthe gel accordingto size, with smallerproductstraveling fartherin the gel becausethey experienceless resistance.
When DNA fragmentsof known size are run in the same gel
(as size standards),the size of the PCR amplificationproducts
can be estimated after the DNA is visualized (e.g., using
ethidiumbromide staining and illuminationwith ultraviolet
light).A given set of primersshouldgeneratea PCRproductof
a particularsize, and the appearanceof an amplificationproduct of the appropriatesize in a gel is consistentwith a positive
PCR.Unfortunately,thereare examplesin which a PCRproduct of the appropriatesize is generated,but the productis not
the intended amplificationproduct.This occurs because of
mispriming,in whichthe primersannealto sites in the genome
(humanor microbial)otherthanthe intendedtargetsequences,
and generatea PCRproductthathappensto be similarin size
to the intendedproduct.
Because nonspecificamplificationproductsmay be generatedin a PCR,the identityof the productsshouldbe confirmed.
methodsincludesequencingof the amplification
Confirmatory
product,annealingof a specific oligonucleotideprobe to a
regionof the amplificationproductthatspansthe primingsites
(e.g., Southernhybridization,slot blotting,probeELISA, and
hybridizationprotection assays), single-strandedconformational polymorphismanalysis,or restrictionenzyme cleavage
of the amplificationproduct(using an enzymeknownto cut a
specific sequencewithin the intendedproduct)with gel electrophoresisof the digest (restrictionfragmentlengthpolymorphism [RFLP] analysis). Although sequencing of the PCR
productis the most rigorousmethodof confirmingamplification productidentity,it is also the most time consumingand
laborious.Most commercialmethodsare likely to use an oligonucleotideprobein an ELISAformat,as this will providea
rapidyet highly specific method of detectinga PCR product
andconfirmingits identity.The TaqMansystem(Perkin-Elmer
Applied Biosystems, Foster City, CA) uses a fluorescently
labeledprobeto detect,confirm,andquantifythe PCRproduct
as it is being generatedin real time (figure3) [9]. This system
obviates the need for postamplificationdetectionand confirmation of product,and thereforereduces assay time. Probebasedconfirmationmethodsalso have the advantageof detecting small quantitiesof amplificationproducts,and thus offer
superiorsensitivity.
Anothermethodused to characterizeandidentifyPCRproducts employsnucleotidesequencesattachedto solid supports,
such as filtersor glass slides. With so-calledDNA chip technology, or high densityDNA microarrays,one can quantitate
and characterizefluorescentlylabeled mRNA or DNA by allowing it to hybridizeto a complementaryDNA sequence(s)
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Figure 3. Real time detection of the human 3-actingene using
TaqManPCRreagents(PEAppliedBiosystems,FosterCity,CA) and
a SmartCyclerhigh speedthermocycler(Cepheid,Sunnyvale,CA). Y
fluorescenceintensity(volts), x
axis = FAM (6-carboxyfluorescein)
axis = PCR cycle number.A fluorescentprobeis releasedfrom the
P-actinPCRproductanddetectedduringPCR.Squares= 1,000,000;
triangles = 100,000;open circles = 10,000;closed circles = 1,000;
open bar = 100;X = 10;closed bar = 0 gene copies.Higheramounts
of startingtargetDNA requirefewer PCR cycles before productis
detected(courtesyof LindaWestern,Cepheid).

anchored to the surface, and subsequent fluorescence scanning
[10, 11]. Tens or hundreds of thousands of sequences (probes)
can be placed within a surface area of 1 cm2. DNA microarrays
have been used to measure in a simultaneous, semiautomated
fashion the mRNA expressed by all Saccharomyces cerevisiae
genes, and -20% of all expressed human genes. In another
application not yet realized one could immobilize thousands of
probes (e.g., 16S rDNA) for different bacterial divisions, genera, and species at a high density. Amplification products from
clinical samples subjected to broad-range 16S rDNA PCR and
incorporating a fluorophore could then be analyzed by comparative hybridization, using this chip to determine which
bacterium or bacteria are present in the sample. The speed and
power of DNA chip technology combined with PCR should not
be underestimated.

Advantages of PCR Over Conventional Diagnostic
Methods
PCR-based assays for the detection of microbial DNA can be
extremely sensitive. Under the right conditions, one can amplify a single copy of a microbial DNA gene or gene fragment
from a clinical sample and detect it. If the microbe contains
multiple gene copies per organism, then one microbe may
provide multiple targets for amplification. For instance, the
bacterium Escherichia coli contains seven copies of the 16S
rRNA gene per organism, so even a fraction of an E. coli (e.g.,
a lysed organism) may be detectable by PCR. Even greater
assay sensitivity can be achieved by amplifying microbial
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targetsthat are presentin large numberswithin a single microbe. One bacteriummay containthousandsof 16S rRNA
copies that are incorporatedinto ribosomesand can serve as
targetsin an RT-PCRassay.In one example,an RT-PCRassay
was designedfor the detectionof T.pallidum 16S rRNA [12].
Using Southernhybridizationto detect the PCR product,the
investigatorswere able to detect 1/100 RNA equivalentsof an
organismin CSF. It may be possible that this RT-PCRassay
couldeven detecta singleorganismthathas lysed andliberated
its rRNAinto the CSF, althoughthe half-lifeof rRNAin CSF
is not known. Althoughstudies of the clinical utility of this
RT-PCRassay have not been published,the assay could revolutionizethe diagnosisof neurosyphilis,since otherdiagnostic
methodsareinsensitive(CSFVDRL)or too cumbersome(rabbit inoculation).
In additionto unrivaledsensitivity,PCRoffersthe potential
for remarkablespecificity.Specificityin PCRderivesfromthe
fact that each distinct microbe has unique DNA. One can
to theseunique
designoligonucleotideprimerscomplementary
segments of DNA, so that only microbial DNA from the
organismbeing sought is amplified.Alternatively,one can
design oligonucleotideprimerscomplementaryto conserved
regionsof microbialDNA so as to detectmorediversegroups
of organisms.If the DNA amplifiedwith this broad-range
approachcontains interveningsegments of DNA that are
uniqueto specificmicrobes,then these microbescan be identified using techniquessuch as sequencingor restrictionenzyme analysis.An exampleof a phylogeneticallyinformative
gene that can be used for both organism-specificPCR as well
as broad-rangePCR is the bacterial16S rRNAgene, as previously mentioned.Whenusing sequenceinformationto identify
a microbe, one avoids the need to grow the organism or
maintainthe organismin a particularphysiologic state for
metabolic analysis. Although a microbe may switch certain
metabolictraitson andoff, leadingto confusionwhentryingto
identify the microbe using traditionalphenotypictests, the
genetic fingerprintof the microbe remains fairly constant,
offeringa more reliablemethodof microbialidentification.
Anotheradvantageto PCR-basedmicrobialdetectionand
identificationis speed. PCR can be completedin minutesto
hours. Simplemethodsto confirmthe identityof the amplification productcan also be completedin minutes to hours.
time of one day is not unrealisticfor
Therefore,a turnaround
of
of microbestends to take
Cultivation
many types assays.
hours to days for initial propagation,and hours to days for
phenotypicdiagnostictesting.Even a rapidlygrowingorganism, suchas E. coli in bloodculture,requiresdaysof laboratory
time before definitiveidentificationis made using cultivation
methodswithphenotypictesting.We areall familiarwith cases
in which a patientdies soon afteran acute,nonspecificflu-like
illness butbeforean organismcanbe grownin culture,suchas
with meningococcalsepsis. These cases remind us that for
easily cultivatableorganisms,cultureis sometimestoo slow to
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be useful.Thisknowledgeinevitablyleadsto the increaseduse
of empiricantibiotics,even for illnesses thatultimatelyprove
to be viral in origin,and to the emergenceof antibioticresistance.A morerapidand sensitivediagnostictest for infection,
suchas PCR,mightreversethis trendtowardempiricismif the
correctmicrobescould be identifiedearly in the infection,and
if this test had a high negativepredictivevalue [13].
Problems and Limitations of PCR
False Positives

Ironically,false positive reactionsare the Achilles' heel of
PCRand stem fromits greateststrength,namelythe incredible
sensitivity of enzymatic amplification.False positive results
occur because PCR may amplify "contaminating"
DNA that
finds its way into a sample,even when thatDNA is presentin
infinitesimallysmall amounts. DNA contaminatessamples
throughseveralmeans.
The most importantmeansof contaminationis throughamplificationproductcarryover.A single PCR can generatebillions of DNA copies, each of which is capable of acting as
target for a future PCR reaction. If even a submicroscopic
portionof a positive amplificationreactiongets into the environmentwheresubsequentPCRreactionsaremixed,thenfalse
positive reactions may ensue. PCR reagents,pipettes, pens,
tubes, tube racks,hands,and doorhandles(almostany object)
are capable of harboringor transmittingPCR amplification
products.To reducethe risks of false positive reactionsfrom
amplificationproductcarryover,laboratoriesare usuallyphysically dividedinto pre-PCRand post-PCRrooms. Some laboratoriesalso have a separateroom for specimendigestionand
processing.All materialsand personnelare supposedto flow
one way, frompre-PCRto post-PCRrooms.Thus,once a PCR
reaction is set up in the pre-PCRarea, it is moved to the
post-PCRarea where amplificationand productanalysis are
performed.Materialsare not allowed into the pre-PCRroom
unless they are new or have been decontaminated.Some labs
have separategowns or disposablegowns for each area.
Amplificationproductcarryovercontaminationcan also be
eliminatedor reducedby using some inactivationtechniques.
In one method,deoxyuridinetriphosphate(dUTP)is used as a
substrate in PCR instead of deoxythymidinetriphosphate
(dTTP). Before each PCR, the reactionmixturesare treated
with the enzyme uracilN-glycosylaseto renderany contaminating(i.e., uracilcontaining)DNA incapableof amplification.
The uracilN-glycosylaseis then inactivatedbeforeproceeding
with PCR. Thymidineremainsintactin the sampleDNA, and
is used as template for new uracil-containingamplification
products.In anothermethod,the PCR reactionscontaindTTP
and isopsoralen,and are treatedwith ultravioletlight afterthe
amplificationstep [14]. Thyminedimersformbetweenthymidine bases, renderingthe DNA incapableof furtheramplification. These methods do not work well for PCR productsof
-100 bp or less in size.
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One approachfor monitoring amplificationproduct carryovercontaminationin samplesor solutionsemploysprimers
thatcontainadditionalsignatureoligonucleotidesat the 5' end
of each primerin orderto maketaggedamplificationproducts.
Bases at the 3' endsof the primersbindto theircomplementary
bases in the targetDNA, providingspecificityin the PCR.The
signaturesequences at the 5' end become incorporatedinto
PCR productsbut do not annealto target.When a sample is
positive, it can be re-testedin a PCR assay using primersthat
are complementaryto the signaturesequences.Amplification
with the signaturesequence primersproves that the sample
containspreviouslyamplifiedtarget,since native targetdoes
not contain this signaturesequence and thereforewill not
amplify. Unfortunately,this method cannot monitorfor episodic contaminationfrom items such as gloves or pipettes,
which may introduceamplificationproductsinto a reaction
withoutdirectlycontaminating
the originalsampleor solutions.
in
However, running samples replicate and repeatingPCR
assays shouldreveal problemswith episodic contamination.
False positive reactionsmay also be causedby intersample
contamination.A clinical samplemay have largequantitiesof
target DNA present.When opening this sample, DNA may
contaminategloves or otheritems in the environment,leading
to the inadvertentintroductionof DNA into otherPCR reactions whereit is amplified.This problemcan be minimizedby
changing gloves between handling of samples, duplicating
sampleanalysis,andavoidingaerosolgeneration.Thisproblem
canbe detectedby interspersingnegativecontrolreactionswith
the test samplesto see if these controlsare positive. Amplification productinactivationwill not controlthis problembecause the contaminatingDNA has not been previouslyamplified.
Anothercauseof falsepositivereactionsoccursin the setting
of broad-rangePCR, e.g., when amplifyingthe bacterial16S
rRNA gene with consensus primers.With primersthat are
complementaryto highly conservedbacterial16S, or fungal
18S rDNA sequencesandhighly sensitivereactionconditions,
one may detectmicrobialDNA uniformly.The negativecontrols arepositivebecausethe PCRreagents,such as waterand
Taqpolymerase,containsmallamountsof bacterialDNA. It is
very difficultto eliminateall contaminatingDNA, especially
from the polymerase enzyme. If one looks carefully, it is
possible to detect small fragmentsof bacterial16S rDNA in
many "sterile"solutions,such as water for injection,and uninoculatedblood culturemedia [15]. Justbecausea solutionis
steriledoes not meanthatit is free of microbialDNA, only that
no microbes can be cultivated.For highly sensitive, broadrangePCRapplications,we may need to createa new standard
for cleanlinessin our reagentsthat measuresmicrobialDNA
insteadof colony-formingunits.
A more subtleproblemwith false positives may arise from
the detectionof small quantitiesof microbialDNA in clinical
samples.If PCR is more sensitivethan culturein some situa-
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tions, then we may need to definewhat constitutesa "significant"level of microbialDNA for a given clinicalsituation.For
instance,what does it mean if S. pneumoniaeDNA is detected
in a blood sample?Althoughthe presence of pneumococcal
DNA in blood would seem to suggest an invasive infection,
this may not alwaysthe case. In one study,whenblood samples
from healthy subjects were examined by PCR, 17% were
positive for pneumococcalDNA (samplesfrom children,not
those from adults) [16]. As with othertests, clinical correlations will need to be madeto see in whatsituationsPCRoffers
an improvementin diagnosticcapabilities,and to determine
what levels of microbial DNA are significant for a given
organism,site, and situation.
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of 1-10/IL, which are addedto a reactionvolume of 20-100
jiL. If one bacteriumis presentin 1 mL of blood, then cultivation of 10 mL of blood has a good chance of detectingthe
organism(assumingthat the organismis cultivatable).PCR
thatis performedon purifiedDNA froma digest of 0.1 mL of
the same blood concentratedto 10 juL may not detect the
organism,dependingon the sensitivity of the assay and the
numberof gene copies of targetpresentin the bacterium.
To increasethe sensitivityof PCR assays, microbialDNA
can be concentrated,such as with sequencecapturePCR [17].
In this technique,microbialDNA is boundto complementary
captureoligonucleotides,which in turn are bound to a solid
support.UnboundDNA and inhibitorysubstancesfrom the
samplearewashedaway. The concentrated,purifiedmicrobial
DNA is then used for PCR.

FalseNegatives
PCR assays for the detection of microbesmay be falsely
negative for several reasons. The sample may contain PCR
inhibitorsthat interferewith amplification.Samplesthat have
been shown to contain PCR inhibitory substances include
blood (heme),blood culturemedia,urine,vitreoushumor,and
sputum. The PCR inhibitorsmust be diluted, removed, or
inactivatedin order to amplify any microbialDNA present.
DNA purificationmethods help to remove many of these
inhibitors,althoughsome inhibitorspersistwhen standardpurificationprotocols are used. Samples may also be falsely
negative because the digestion step has failed to release the
microbialDNA presentor because the DNA has been lost in
the purificationstep. Microbeswith thick cell walls, such as
fungi or bacterialspores, may be difficultto breakopen and
thereforemay requireadditionalmechanicalor enzymaticlysis
steps in orderto liberatemicrobialDNA for amplification.
Amplificationof a humangene can help monitorfor PCR
inhibitorsandcheckthe qualityof the DNA presentin a sample
of human tissue subjectedto PCR for the detection of microbes. For instance,if PCR using primerscomplementaryto
the humanj-globin gene fails to yield a PCR productwith a
human tissue sample, then that sample is problematic.The
problemsample should be checked for the presenceof PCR
inhibitorsand DNA. If a tissue sample is 3-globinPCR negative,thena negativeresultin a microbialDNA PCRassayhas
no meaning,since amplifiableDNA may not be present.If a
sample is ,3-globin PCR positive but microbial DNA PCR
negative,then the sample is more likely a "true"negativefor
microbialDNA. Obviously,this approachwill not work with
any procedurein which human DNA is removed (e.g., see
sequencecapturebelow and [17]). Some PCR kits containan
internalamplificationstandardthat allows one to monitorinhibitoryactivityand test performancein each sample.
PCR-basedassays may also be negativebecauseof analysis
of an inadequatesamplevolume.Largevolumesof fluidcanbe
cultivated,such as 10-20 mL of blood. On the other hand,
samplevolumes areusuallyvery small with PCR,in the range

Sample Acquisition and Preparation
One should be mindful that the sample collection process
can have a significantimpacton the outcomeof the PCRassay.
Tissuesandfluidsshouldbe refrigeratedandrapidlyprocessed,
or storedfrozenin orderto preservethe DNA for amplification.
Nucleasespresentin fluids can degradeDNA, so storagein a
magnesium-freeenvironment(e.g., with EDTA), at low temperatures,or in chaotropicsolutions is helpful. In the field,
where freezers are not available, tissues can be stored in
ethanolor a chaotropicsolutionsuch as guanidineisothiocyanate. Fixationof tissues in formaldehydeand otherpathological fixativesolutionscan damageDNA, particularlywith prolonged fixationtimes. Fixationshould be avoided if samples
are being collectedprospectivelyfor PCR analysis.
When using broad-rangePCR, such as with conserved16S
rDNA primers,one mustbe carefulin selectingthe tissue and
anatomicalsite of acquisition.Broad-rangebacterialPCRwill
detect normalbacterialflora, and thus should be applied to
tissuesthatareusuallyfree of bacteriasuchas blood, CSF, and
brain. Broad-rangePCR using tissues that are normally in
contact with bacteria, such as the mouth, colon, and skin,
makes interpretation
of the resultschallengingbecausemultiple PCR productsmay be generated.When a heterogeneous
collection of PCR productsis generated,these must be individually identifiedto sort out which sequencecomes from a
pathogen,andwhich sequencecomes froma normalcolonizer.
There are many protocols for sample digestion and DNA
purification. Some digestion methods employ mechanical
means such as freezing-thawing,sonication, agitation with
glass beads or ceramicparticles,or crushingwith mortarand
pestle. Other methods use chemical or enzymaticmeans to
break open microbes, such as using chaotropes,detergents,
proteases,or other enzymes active on microbialcell walls.
Some methods or combinationswork well for selected microbes, but there is presentlyno universalmethodoptimized
for digestingall microbesin all tissues. Similarly,certainDNA
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purificationprotocolswork well with certainsamples.This is
unfortunatebecauseone would like to have a universaldigestion and DNA purificationprotocolthat one could use in the
clinical microbiologylab for all samples destined for PCR.
DNA and RNA purificationsystemsare availSemiautomated
able for use in the clinical microbiologylaboratory.
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isms that are prone to developingresistance,the lack of susceptibility data is problematic.Yet PCR can play a role in
determiningantibioticsusceptibility.PCR assays have been
designed for the detection of antibioticresistancegenes in
microbes, such as the methicillinresistancegene (mecA) in
Staphylococcusaureusandmutationsin the rifampinresistance
gene (rpoB) in Mycobacterium tuberculosis. Although the

Cost
PCR is expensive. For example, our clinical microbiology
laboratorycharges$125 for a herpessimplexvirus(HSV) PCR
assay using CSF. The cost of PCR reagentsand equipmentis
substantial.The requirementfor separatepre-PCRand postPCRareasmeansthatmolecularmicrobiologylaboratoriesuse
a disproportionateshare of laboratoryspace. Furthermore,
there are trainingcosts associatedwith teachingmicrobiologists to performthese moleculardiagnosticassays. Will PCRbasedassays ever competewith traditionaldiagnosticmethods
such as cultivationand serology?
For certain diagnostic tests, such as HSV PCR for the
diagnosisof encephalitis,PCR is currentlymore cost effective
thanpreviousdiagnosticapproaches(see below and [18]). The
advantagesto PCR-basedtests, such as speed and sensitivity,
may offset higherdiagnosticcosts by reducinghospitalization
and treatmentcosts. However,these indirectcost advantages
are difficultto quantify.As the budgetsof clinical microbiology labs continue to shrink,administratorswill look to the
more easily quantifiablebottomline of the laboratory,andwill
demandthatPCR-basedassays be cost competitivewith other
diagnosticmethods.The directcosts of PCR-baseddiagnostics
will likely decreaseas this technologybecomes more refined.
Some PCR assays such as the Chlamydiaand Neisseria gonorrhoeaeassays have directcosts in the $8-10 rangeand are
alreadycost competitivewith culturetechnology.Miniaturization of PCR reactionsand the use of high throughputrobotics
technologywill likely lead to substantialcost reductions.Increased use of PCR-basedmethods may also reduce costs
throughcompetitionand reducedlabor costs. For certainmicrobes,PCR is the only diagnosticapproach,and thus thereis
no basis for a cost comparison.For instance the Whipple
bacillus, T. whippelii,cannotbe detectedusing methodssuch
as cultureand serology, leaving PCR as the most definitive
diagnostictest, althoughhistologyand electronmicroscopyof
tissues may also suggest the diagnosis.
Antibiotic Susceptibility and Resistance
PCR amplification of phylogenetically informative sequencessuch as the 16S rRNAgene fails to providedataabout
the antibioticsusceptibilityof the organism.One advantageof
cultivationis that a susceptibilityprofilecan usuallybe determined in orderto help guide treatment.For organismswith
stableantibiograms,this functionis less important.For organ-

presence of a resistancegene in a microbe does not always
imply expressionof that gene and phenotypicresistance,its
absencedoes imply a lack of resistancethroughthatparticular
geneticmechanism.In the future,multiplexPCRor microarray
technologymay help to identifyboth the microbeand determine antibioticsusceptibilityprofilesin one reaction.

PCR in Practice: HSV PCR for the Diagnosis of Herpes
Encephalitis
An excellent example of an organism-specificPCR-based
assay is HSV PCRfor the diagnosisof herpessimplexencephalitis (HSE). The previousgold standardfor the diagnosisof
HSEwas brainbiopsywith cell culture.The cost andmorbidity
of this diagnostictest were high, mostlyrelatedto the need for
general anesthesiaand craniotomy.The significanteffort requiredto make the diagnosisby brainbiopsy led some clinicians to treat patientsempiricallywith acyclovir ratherthan
pursuethe diagnosis.Althoughthereis littletoxicityassociated
with acyclovir, the lack of a definitive diagnosis may have
hinderedfurtherdiagnosticevaluationof patientshavingother
causes of encephalitis.
WithHSV PCR,CSF is obtainedfromthe patientby lumbar
punctureand assayed,avoidingthe need for the moreinvasive
brainbiopsy. CSF is addedto a PCRreactionmixturecontaining primersthat are complementaryto regions in the DNA
polymerasegene or the glycoproteinB gene of HSV-1 and
HSV-2. The assay can detect about 20 gene copies of either
herpesvirus.Thepresenceof HSV DNA in the CSF of a patient
with encephalitisis sufficientto make the diagnosisof HSE.
Thistest is morerapidthancultureandis sensitiveandspecific.
It is less costly (consideringthat the costs of surgery and
anesthesiarun into thousandsof dollars), less invasive, and
producesless morbidityand mortalitythandoes brainbiopsy.
Given the advantagesof PCR for the diagnosisof HSE, there
is now little reason to perform brain biopsies on patients
suspectedof havingthis diagnosis.
The HSV PCRassayprovidesan exampleof how difficultit
can be to comparea new diagnostictest to a gold standard
when the gold standardis not very golden. In one study that
comparedPCRto biopsy with culture,53 of 54 biopsy-proven
patientswith HSE were also positiveby PCR (98%) [18]. It is
of interestthatthreeof 47 biopsynegativepatientswere found
to be PCR positive (6%). How does one interpretthe results
when a novel test (PCR) picks up more cases than the gold
standard(brainbiopsy)?Are the additionalcases false positives
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with the new diagnostictest, or false negativeswith the gold
standard?Review of the laboratoryand clinical datafromthis
study suggests that the positive PCR results in these biopsy
negative patients are true positives that are due to errorsin
sample acquisitionthat led to negative cultureresults (e.g.,
placingthe brainin formalinbeforeculture).BecauseHSE can
be a patchyprocess,biopsy may miss areasof involvement.If
the threePCRpositivebutbiopsynegativecases areconsidered
to be truepositives,thenHSV PCRis the moresensitivetest in
this study. HSV PCR for the diagnosis of HSE will likely
become the new gold standard.

Specific PCR Assays
A numberof commerciallyavailablePCR assayshave been
designed for the detectionof specific microbes [1, 2]. These
assays use primersthatare complementaryto uniquestretches
of DNA present in a given microbe's genome. Assays are
available for a variety of pathogens, including HIV, HSV,
hepatitisB virus,hepatitisC virus, cytomegalovirus,enterovirus, Chlamydia trachomatis, M. tuberculosis, Mycobacterium
avium complex, T. whippelii, and Neisseria gonorrhoeae.

Threeof these assays are discussedbelow.
RT-PCRis used to detectviralload in an assayof HIV RNA
(MONITOR,Roche, Branchburg,NJ). The targetis a segment
of the HIV-1 gag gene. The assaynormallydetectsas few as 50
of
gene copies per milliliterof plasmaafterultracentrifugation
the sampleto concentratevirions,and can be used to monitor
the effectiveness of antiretroviraltherapy.The PCR product
binds to a probe-coatedmicrowell plate, and a colorimetric
assay quantitatesthe target.A modifiedtarget,called a quantitation standard,is added to the reactionso that HIV copy
numbercan be determined.Plasmashouldnot be collected in
heparin,as it is a PCR inhibitor.
A PCR assay for C. trachomatistargets a segment of a
crypticplasmid,and is able to detect 10 plasmidcopies, or 1
inclusion-formingunit (Amplicor, Roche). The assay is so
sensitivethaturinecan be used to screenpatientsfor infection,
avoidingthe need for more invasive examination,and thereby
facilitatingthe acquisitionof patients'samples.PCR is more
sensitive than cell culture.A cultureshould still be obtained
when collecting legal evidence, such as for cases of rape or
childabuse,as PCRresultsmay not be legally acceptableproof
of infection. Endocervicaland urethralswabs can also be
tested. The assay does not detect plasmid-freevariants of
C. trachomatis,andurineshouldnot be frozen,but storedin a
refrigerator.Spermicideand surgicallubricantcan act as PCR
inhibitors,producingfalse negativereactions.
A PCR assay is available that detects a segment of the
T. whippelii 16S rRNA gene for the diagnosis of Whipple's
disease (Mayo Clinic, Rochester,MN). The assay can detect
<100 copies/mLof samplefluid. PCR is more sensitivethan
histologyfor diagnosis.PCRis also moreusefulthanhistology

CID 1999;29 (September)

for monitoringresponse to antibiotictherapybecause histologic resolutionof intestinallesions may takemonthsto years,
whereas PCR-basedevidence of infection tends to correlate
with disease resolutionor relapse[19].
Broad-Range PCR
Bacteria isolated by cultivationcan be identifiedusing a
commerciallyavailable broad-range16S rDNA PCR assay
with sequencingof the amplificationproduct.This genotypic
identificationmethodwas shown to be superiorto other(phenotypic)methodsof microbialidentificationwhen appliedto a
series of fastidiousaerobicgram-negativebacilli [20]. However, broad-rangePCR for the direct detectionof microbial
DNA in clinical specimensremainsan experimentalapproach
[8]. This approachis hobbledby the presenceof contaminating
DNA in PCRreagents,whichpreventsthe use of very sensitive
PCR conditions. In addition, when multiple organismsare
present in a sample, direct sequencingof the amplification
productcannotbe performedbecause there are mixed amplificationproducts.These multiplesequencetypes must be distinguishedby methods such as cloning, single-strandedconformationalpolymorphismanalysis, or group-specificprobe
hybridization.Broad-rangeconsensus PCR with direct sequencingcan be successfullyappliedto clinical samplesthat
containa single organism.
The gene targetsthathave been successfullyused in broadrangeconsensusPCR assays for the identificationand phyloof microbesincludethe small subunit
genetic characterization
ribosomalRNA genes (16S rDNA in prokaryotes,and 18S
rDNA in eukaryotes),the citratesynthasegene, andheat shock
protein genes. Phylogenetically informative gene targets
shouldhave regionsof sequenceconservationfor the designof
broad-rangeprimers,and areasof sequencediversityto distinguish between organisms. The value of a gene target for
broad-rangePCR dependsin parton the diversityand number
of microbialsequencetypes from that targetpresentin databases, as well as the reliability of that locus in reflecting
organismalevolutionaryhistory.For the small subunitrRNA
gene, there are >9,000 sequences from differentorganisms
presentin databases,makingthis a useful gene for identifying
a microbe or determiningits close evolutionaryneighbors.
Primershave been describedfor broad-rangebacterialor fungal PCR assays, but there are no primersthat can detect all
groupsof viruses.Thereis too muchsequencediversityin viral
genes to design a broad-rangeviral consensus PCR assay.
to conserved
However,one can designprimerscomplementary
in
viral
such
as
the DNA
certain
families,
genes segments
of
polymerasegene herpesviruses.
The Future of PCR: Technical Advances
Advancesin nucleicacidamplificationtechnologywill make
futurediagnostictests fasterand less expensive[21]. PCRhas
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been miniaturizedso that nanoliterquantitiesof sample are
processed within a few minutes. For instance, high speed,
continuousflow PCRhas been performedon a glass microchip
in which the sample is moved rapidlybetween thermostated
temperaturezones [22]. Using this microdevice,20 cycles of
PCR could be performedin as little as 90 seconds. Similarly,
small-volume,rapidPCRhas beenperformedin microcapillary
tubes and micromachinedsilicon chip-based reactionchambers. The disadvantageof smallvolume PCR for the detection
of microbesis thatorganismspresentin low concentrationsin
a samplemay be missed. This limitationcan be overcomeby
samplepreparationmethodsthatconcentratemicrobialnucleic
acids, or by continuousflow/multiplesamplingmethodsthat
increase the volume of sample analyzed.The advantagesof
small-volumePCRincludereducedcost fromthe use of fewer
reagents,and the ability to analyzenumerousaliquotsfrom a
clinical sample so that multipletests can be performedon a
limitedvolume of tissue or fluid.
Anotheradvancein PCR-baseddiagnosticsis real time detectionof PCRproducts.For instance,the TaqMansystem [9]
uses a fluorescentlylabeledprobeandthe exonucleaseactivity
of Taqpolymeraseto monitorthe formationof productas it is
being generated(figure3). Real time detectionmethodscan be
combined with miniaturized,rapid PCR technologies. With
currentlyavailabletechnology,it is possible to design a microchip or microcapillaryPCR apparatusthat can amplify,
detect, and characterizea microbialDNA targetwithin minutes.

Questions without Answers
The applicationof PCR to the detection of microbes in
clinical samples raises several questions.How long does microbialDNA persistin tissues afterdisease resolutionor antibiotic treatment?Does microbialDNA from some microbes
persistin certaintissues or body fluids afterviable organisms
aregone?Does microbialDNA increasein the blood afterlysis
of organismsat a distanttissue site, such as with use of cell
wall active antibiotics?Is the presence of bacterialRNA a
betterindicatorof currentinfectionwith viable organismsthan
bacterialDNA? Whatis a clinicallysignificantlevel of microbial DNA at a particularsite? How can PCR distinguishbetween colonization,latent infection, active infection, and relapsing infection? Is microbial DNA routinely found in
"sterile"sites sampledfrom normalindividuals?
A few animalstudieshave attemptedto addressthese questions. Witha mousemodelof Lymedisease,investigatorswere
able to show by PCR that Borrelia burgdorferiDNA disappearedfromtissues immediatelyaftera 5-day antibiotictreatment course, and that the PCR resultscorrelatedwith culture
results[23]. This studysuggeststhatthe responseto antibiotics
for Lyme disease might be monitoredby PCR. Similarly,
investigatorsusing a chinchillamodel of otitis media found a
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strong correlationbetween PCR results and culture results
when animalswere injectedwith viable H. influenzae.When
animals were injected with purifiedbacterialDNA or with
killed bacteria,the amplifiableDNA rapidlydisappeared[24].
In a rabbit model of syphilis in which live or heat-killed
T. pallidum was injectedinto the skin and testes, heat-killed
treponemeswere no longer detectableby PCR after 15-30
days, whereas viable organismswere detected by PCR for
months [25]. These studies suggest that bacterial DNA is
clearedfromthe tissuesites of animalsafterbacterialdeath,but
that the DNA from different microbes may have different
eliminationkineticsat differentsites.
Humanstudieslookingat the persistenceof microbialDNA
by PCRare few, but includea studyof pulmonarytuberculosis
treatmentthat showedthat sputumsmearsand culturesfor M.
tuberculosisconvertto negative before PCR results,but that
PCR results do correlatewith clinical responseto antibiotics
andalso canpredictrelapse.It is not clearif the persistentPCR
signal seen in some of these patientsis due to low levels of
viable organisms,or due to amplifiableDNA from nonviable
organisms[26]. A study of PCR for the detectionof T.pallidum in CSF from patients with neurosyphilissuggests that
bacterialDNA may persistfor years afterantibiotictreatment
[27]. However,the episodicallypositive PCRresultsfromthis
studymay insteadbe due to false positive reactions,since the
investigatorsused a nested PCR assay with its high potential
for contamination.A study of HSV PCR for herpesencephalitis suggested that HSV DNA may persist in CSF for 2-3
weeks afterinitiationof effective treatment[18].
Answers to these questionswill requireclinicians and researchersto comparecarefullyPCR-basedmicrobialdetection
methodswith existing diagnosticmethods.Only with further
experiencewill the benefits and limitationsof PCR become
fully apparent.

Conclusions
PCR is a powerfultechniquethat is increasinglyappliedto
the diagnosisof infectiousdiseases. PCR-basedassays detect
microbialnucleic acid in clinical samplesand do not require
growthof the organism.PCR-basedassays can be fast, sensitive, and specific, but may also be associatedwith technical
problemssuch as false positive reactionsdue to sample contamination,and false negativereactionsdue to the presenceof
PCR inhibitorsin the sample. As the cost of PCR reagents
decline,andas the numberof PCR-basedapplicationsincrease,
the clinical microbiologylaboratoryof the future will look
increasinglylike a molecularbiology laboratory.Panels of
PCR assays are likely to be developed, targetingmicrobes
involvedin specificsyndromessuchas pneumonia,meningitis,
anddiarrhea.Ratherthanhavingto growan intactmicrobe,one
will be able to "grow"a segmentof its DNA, replacingculture
media with PCR reaction mix, and the incubatorwith the
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thermal cycler. PCR-based diagnostic tests offer clinicians a
powerful new weapon to add to their quivers. We are long
overdue for rapid, sensitive diagnostic tests in infectious diseases that allow clinicians to make sound judgments in real
time. The diagnosis of Rocky Mountain spotted fever should be
confirmed within hours of presentation, not days later at autopsy, or weeks later in convalescence. PCR and other molecular diagnostic methods hold the hope of making rapid diagnosis and directed therapy a reality.
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